Pantoprazole Injection Market
Global Pantoprazole Injection Market Size, Share and Trends Analysis Report, By Type (Gastroesophageal Reflux Disease (GERD), Ulcers, Zollinger-Ellison Syndrome, and Other (Erosive Esophagitis), By Application (Hospitals, Special Clinics, Recovery Centers, and Others), Forecast Period (2022-2028)
The global pantoprazole injection market is anticipated to grow at a significant CAGR of 3.2% during the forecast period. The increasing prevalence of GERD and other stomach-related illnesses is the prominent factor that has boosted the high demand for pantoprazole. As per the American Academy of Family Physicians, GERD affects an estimated 25 to 35% of the US population every year. Moreover, the prevalence of GERD is 18.1–27.8% in North America, 8.8–25.9% in Europe, 2.5–7.8% in East Asia, 8.7–33.1% in the Middle East, 11.6% in Australia, and 23.0% in South America, according to the Korean Society of Neurogastroenterology and Motility. The increase in GERD prevalence may be due to multiple factors such as older age, intake of analgesics, consumption of certain types of food and drinks, smoking, or history of GERD in the family. The increasing prevalence may increase the demand and adoption of the drug among the population, which in turn will drive pantoprazole injection market growth.
Pantoprazole (which belongs to the class of proton-pump inhibitors) is a drug prescribed to treat damage from erosive esophagitis, and gastroesophageal reflux disease (GERD). The conditions cause heartburn and possible injury of the esophagus due to the backward flow of acid from the stomach, in adults and children 5 years of age and older. The drug also found its effective use and application in the treatment of conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome in adults.
However, long-term use of pantoprazole can lead to an increased risk of certain side effects and complications such as nausea or vomiting, diarrhea, gas, and others, which is the prominent factor that may limit its adoption on a wider level during the forecasted period. The surging approvals of new drugs developed by players contributing to the pantoprazole injection market are likely to bring new growth opportunities to the market.
Segmental Outlook
The global pantoprazole injection market is segmented based on type and application. Based on type, the market is sub-segmented into GERD, ulcers, Zollinger-Ellison syndrome, and others (erosive esophagitis). Based on application, the market is further classified into hospitals, special clinics, recovery centers, and others. Among these, the hospital segment emerged as the fastest-growing during the forecast period. Pantoprazole injections are widely used in hospitals the patient to prevent gastrointestinal bleeding and as heartburn/gastroesophageal reflux disease relief after discharge. Patients affected with GERD need to take pantoprazole injections on daily basis for up to 7 to 10 days under the supervision of a doctor or nurse in a medical facility. Apart from these factors, the rising number of hospitals coupled with better healthcare facilities support patients to get better treatment, which in turn drives segment growth.
Regional Outlook
Geographically, the global pantoprazole injection market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, ASEAN, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). North America is expected to be the dominant region during the forecast period owing to the increasing healthcare investment and increased USFDA approvals of drugs used in the treatment of GERD and other stomach disorders. For instance, Aurobindo Pharma received approval from the USFDA for the development and marketing of pantoprazole sodium injection for the treatment of gastroesophageal reflux infection.
Global Pantoprazole Injection Market Growth By Region, 2022-2028
Asia-Pacific Emerge as the Fastest-Growing Region in Pantoprazole injection Market
Geographically, Asia-Pacific will predict an ascent in its market development due to rising cases of gastroenterology-related diseases. As per the World Cancer Research Fund’s annual ranking of the top 20 countries with the highest incidence of stomach cancer, counties in Asia-Pacific such as Korea (42 per 100,000), Japan (30 per 100,000), and China (23 per 100,000) ranked as numbers 1, 3, and 5 respectively. Apart from the high prevalence, the presence of the geriatric population affected with various types of stomach diseases is also a prominent factor that has surged the demand for drugs and motivated the market players to come up with new product development.
Market Players Outlook
The major market players in the global pantoprazole injection market include Abbott, Aristo Pharmaceuticals, AuroMedics Pharma LLC, Cipla Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals PLC, Pfizer Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical, among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global pantoprazole injection market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Pantoprazole Injection Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on key players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Pantoprazole Injection Market by Application
5.1.1. Gastroesophageal Reflux Disease (GERD)
5.1.2. Ulcers
5.1.3. Zollinger-Ellison Syndrome
5.1.4. Other (Erosive Esophagitis)
5.2. Global Pantoprazole Injection Market, By Application
5.2.1. Hospital
5.2.2. Special Clinic
5.2.3. Recovery Center
5.2.4. Others
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. South Korea
6.3.5. Rest of Asia-Pacific
6.4. Rest of the World
6.4.1. Latin America
6.4.2. Middle East & Africa
7. Company Profiles
7.1. Abbott Laboratories
7.2. Aristo Pharmaceuticals
7.3. AuroMedics Pharma LLC
7.4. Sihuan Pharmaceutical Holdings Group, Ltd.
7.5. Cipla, Ltd.
7.6. Lee Pharma, Ltd.
7.7. Dr. Reddy’s Laboratories, Ltd.
7.8. Hikma Pharmaceuticals PLC
7.9. Jinzhou Jiutai Pharmaceutical
7.10. Pfizer, Inc.
7.11. Reyoung Pharmaceutical Co., Ltd.
7.12. Sun Pharmaceutical Industries Ltd.
7.13. Taj Pharmaceutical Ltd.
7.14. Takeda GmbH
7.15. Teva Pharmaceutical Industries Ltd.
7.16. Wellona Pharma
1. GLOBAL PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL PANTOPRAZOLE INJECTION FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL PANTOPRAZOLE INJECTION FOR ULCERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL PANTOPRAZOLE INJECTION FOR ZOLLINGER-ELLISON SYNDROME MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL PANTOPRAZOLE INJECTION FOR OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
7. GLOBAL PANTOPRAZOLE INJECTION IN HOSPITAL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL PANTOPRAZOLE INJECTION IN SPECIAL CLINIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL PANTOPRAZOLE INJECTION IN RECOVERY CENTER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL PANTOPRAZOLE INJECTION IN OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. NORTH AMERICAN PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
13. NORTH AMERICAN PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
14. NORTH AMERICAN PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
15. EUROPEAN PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. EUROPEAN PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
17. EUROPEAN PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
21. REST OF THE WORLD PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
22. REST OF THE WORLD PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
23. REST OF THE WORLD PANTOPRAZOLE INJECTION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. GLOBAL PANTOPRAZOLE INJECTION MARKET SHARE BY TYPE, 2021 VS 2028 (%)
2. GLOBAL PANTOPRAZOLE INJECTION MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
3. GLOBAL PANTOPRAZOLE INJECTION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
4. GLOBAL PANTOPRAZOLE INJECTION FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
5. GLOBAL PANTOPRAZOLE INJECTION FOR ULCERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL PANTOPRAZOLE INJECTION FOR ZOLLINGER-ELLISON SYNDROME MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL PANTOPRAZOLE INJECTION FOR OTHER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL PANTOPRAZOLE INJECTION IN HOSPITAL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL PANTOPRAZOLE INJECTION IN SPECIAL CLINIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL PANTOPRAZOLE INJECTION IN RECOVERY CENTER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL PANTOPRAZOLE INJECTION IN OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL PANTOPRAZOLE INJECTION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. US PANTOPRAZOLE INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
14. CANADA PANTOPRAZOLE INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
15. UK PANTOPRAZOLE INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
16. FRANCE PANTOPRAZOLE INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
17. GERMANY PANTOPRAZOLE INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
18. ITALY PANTOPRAZOLE INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
19. SPAIN PANTOPRAZOLE INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
20. REST OF EUROPE PANTOPRAZOLE INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
21. INDIA PANTOPRAZOLE INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
22. CHINA PANTOPRAZOLE INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
23. JAPAN PANTOPRAZOLE INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
24. SOUTH KOREA PANTOPRAZOLE INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF ASIA-PACIFIC PANTOPRAZOLE INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF THE WORLD PANTOPRAZOLE INJECTION MARKET SIZE, 2021-2027($ MILLION
